Tofaxen 5 MG (Tofacitinib)

Basic Product Information of Tofaxen 5 MG (Tofacitinib)

How Tofaxen 5 MG (Tofacitinib) Works: JAK-STAT Inhibition Mechanism

Tofacitinib, the active ingredient in Tofaxen 5 MG, is a Janus kinase (JAK) inhibitor that acts mainly on JAK1 and JAK3, with lesser activity on JAK2. JAK enzymes sit inside immune cells and pass signals from cytokine receptors on the cell surface to the nucleus through signal transducers and activators of transcription (STAT) proteins. This chain of events is called the JAK-STAT pathway.

In autoimmune disease, cytokines such as interleukin-6 (IL-6), interleukin-2, interleukin-7, interleukin-15, interleukin-21, and interferons overactivate this pathway, which keeps immune cells inflamed and damages joints or the intestinal lining. Tofacitinib blocks the pathway inside the cell, so it dampens signaling from several cytokines at once instead of neutralizing one cytokine outside the cell as TNF blockers do. Because the drug lowers immune activity, clinicians screen for tuberculosis and other infections before treatment and follow malignancy risk during long-term use. Teams managing patients with both immune disease and cancer history can review the broader oncology medicines catalogue at Mediaid Pharmacy.

In the ORAL Solo trial, 59.8% of patients with rheumatoid arthritis reached an ACR20 response at month 3 on tofacitinib 5 mg twice daily, compared with 26.7% on placebo. In ORAL Standard, ACR20 response at month 6 was 51.5% on tofacitinib 5 mg twice daily versus 28.3% on placebo and 47.2% on adalimumab. An ACR20 response means at least a 20% improvement in tender and swollen joint counts plus other disease measures.

Approved Indications of Tofacitinib (Reference Label for Tofaxen 5 MG (Tofacitinib))

Tofacitinib, the active ingredient in Tofaxen 5 MG, is approved internationally in the following adult conditions. Prescribers should confirm the exact indications on the product label supplied with their import.

Key Clinical Benefits of Tofaxen 5 MG (Tofacitinib)

How to Take Tofaxen 5 MG (Tofacitinib): Dosage Guidelines

Clinical Monitoring Requirements During Tofaxen 5 MG (Tofacitinib) Treatment

Screening and monitoring are mandatory. Before starting tofacitinib, clinicians test for latent and active tuberculosis and screen for hepatitis B and hepatitis C. The reference label advises against starting treatment when the absolute lymphocyte count is below 500 cells per cubic millimeter, the absolute neutrophil count is below 1,000, or hemoglobin is below 9 g/dL.

Laboratory monitoring includes lymphocyte counts, neutrophil counts, and hemoglobin at baseline, 4 to 8 weeks after starting, and every 3 months afterward. Lipid panels are checked 4 to 8 weeks after starting because tofacitinib raises total cholesterol, LDL, and HDL. Liver enzymes are monitored routinely. Patients should also receive zoster vaccination before treatment when possible, avoid live vaccines during therapy, and undergo periodic skin examinations, since lymphoma, lung cancer, and non-melanoma skin cancer have been reported.

Drug Interactions and Important Safety Information for Tofaxen 5 MG (Tofacitinib)

Tofacitinib is cleared mainly through CYP3A4 metabolism, with a smaller contribution from CYP2C19. Strong CYP3A4 inhibitors such as ketoconazole raise tofacitinib exposure and require a dose reduction, and strong inducers such as rifampin lower exposure and reduce efficacy. Combination with potent immunosuppressants such as azathioprine, cyclosporine, or tacrolimus, and with biologic DMARDs, is not recommended because it increases the risk of serious infection.

Patients must tell their physician about all prescription medicines, over-the-counter products, and herbal supplements before starting Tofaxen 5 MG. Women of reproductive potential must use effective contraception during treatment and for at least 4 weeks after the final dose. Breastfeeding is not advised during treatment and for 18 hours after the final dose.

Side Effects and Precautions of Tofaxen 5 MG (Tofacitinib)

Who Should Use Tofaxen 5 MG (Tofacitinib)?

Tofaxen 5 MG (Tofacitinib) is prescribed for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or ulcerative colitis who have not responded adequately to conventional therapy, and in many labels to one or more TNF blockers. Patients with active serious infection, severe hepatic impairment, or a history of blood clots require careful specialist evaluation, and those aged 50 or older with cardiovascular risk factors or a history of malignancy need an individual risk-benefit review. Tofaxen 5 MG is prescribed by rheumatologists and gastroenterologists experienced with JAK inhibitor therapy. Buyers who supply patients with complex immune and cancer care needs can also source medicines from the Mediaid Pharmacy oncology specialty medicines range.

Global Supplier: Mediaid Pharmacy Worldwide Shipping for Tofaxen 5 MG (Tofacitinib)

Mediaid Pharmacy is a Dhaka-based supplier of specialty and oncology medicines with worldwide shipping. Tofaxen 5 MG (Tofacitinib) is available under an Export Only registration in a 60’s tablet pack, so orders are handled for importers, hospitals, and distributors in destination markets with the necessary import authorization. Our team provides pricing quotations, stock confirmation, documentation, and delivery tracking through WhatsApp, phone, or WeChat for all questions about Tofaxen 5 MG Tofacitinib. Importers who need several products in one consignment can review the complete oncology medicine collection and request a combined quotation.

Why Choose Tofaxen 5 MG (Tofacitinib) from Mediaid Pharmacy?

Tofaxen 5 MG (Tofacitinib) gives importers and healthcare providers an export-supplied tofacitinib tablet for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis, backed by the evidence from the ORAL and OCTAVE clinical programs. Mediaid Pharmacy provides clear product specifications, direct specialist support, and worldwide shipping for every order, and each enquiry is handled as a prescription-based or licensed-buyer request. To source additional specialty therapies, visit the Mediaid Pharmacy oncology medicines section, then contact our team for a personalized quotation.

Frequently Asked Questions About Tofaxen 5 MG (Tofacitinib)